Skip to main content

Global Orthopedic Implants Market Size [2022-2028] worth USD 64.18 Billion, with 5.1% CAGR

Key Prominent Players Covered in the Orthopedic Implants Market are Zimmer Biomet (Indiana, U.S.), Medtronic, DePuy Synthes Companies (Johnson & Jonson Service Inc.) (Raynham, U.S.), Smith & Nephew (London, U.K.), Stryker (Michigan, U.S.), ArthoCare Corporation (Texas, U.S.), BioTek Instruments Inc. (Vermont, U.S.), CONMED Corporation (New York, U.S.), Integra LifeSciences Corporation (Massachusetts, U.S.)

Pune, India, Jan. 24, 2022 (GLOBE NEWSWIRE) — The global orthopedic implants market size is anticipated to hit USD 64.18 billion by 2028 and exhibit a CAGR of 5.1% during the forecast period. The expanding geriatric population and the rising orthopedic injuries prevalence are expected to boost the market growth. Fortune Business Insights™ presents this information in its report titled, “Orthopedic Implants Market, 2021-2028”. The market size stood at USD 43.16 billion in 2020.

The growing demand for customized joint implants is anticipated to provide significant growth impetus to the market. The major players in the market are focused on developing cutting-edge technologies to provide technically advanced joint implants. The rising technological advancements in these implants are likely to bolster the market’s growth in the upcoming years.

Industry Developments-

  • July 2021: Orthofix Medical Inc. launched a patient implant with fiberFUSE strip. The product is a cutting-edge demineralized bone-graft solution.


Request a Sample Copy of the Research Report:

https://www.fortunebusinessinsights.com/enquiry/sample/orthopedic-implants-market-101659


Drivers & Restraints-

Rising Technological Advancements to Boost Market Growth

  • Large medical device companies leverage modern technologies to produce implants according to the patient’s anatomy. The unique anatomy of each patient requires a customized joint implant.
  • Hence, the growing demand for customized joint implants is likely to complement the market growth.
  • Due to the growing demand for customized orthopedic implants, the companies are focused on developing cutting-edge technologies to provide technically advanced implants. Therefore, the growing emphasis on technological advancements in these implants is likely to bolster the global orthopedic implants market growth.

Low bone density issues, osteoarthritis, degenerative disc diseases, and other such bone-related issues are widely found in the geriatric population above 60 years of age. The geriatric population is consistently rising and is likely to stimulate market growth. Additionally, the surging prevalence of orthopedic injuries is anticipated to augment the market growth.
However, the high costs of orthopedic implants and the price transparency barriers are likely to hinder the market’s growth.


Click here to get the short-term and long-term impact of COVID-19 on this market.

Please visit:

https://www.fortunebusinessinsights.com/industry-reports/orthopedic-implants-market-101659


Regional Insights-

Expanding Geriatric Population to Propel Growth in North America

North America is projected to hold the largest portion of the global orthopedic implants market share. The increasing geriatric population and the rising number of patients suffering from osteoarthritis are anticipated to boost the growth of the market. Europe is expected to witness robust growth due to the increased prevalence of chronic diseases, including diabetes and bone diseases.

Asia Pacific is anticipated to gain immense growth due to improving levels of personal disposable income, flourishing medical tourism, and improving healthcare infrastructure.
The Middle East & Africa, and Latin America are likely to witness sluggish growth due to fewer orthopedic surgeons and low-income development.


Quick Buy – Orthopedic Implants

https://www.fortunebusinessinsights.com/checkout-page/101659


Competitive Landscape-

Key Players Adopt Ingenious Growth Strategies to Improve Market Positions

The market is dominated by Stryker, DePuy Synthes Companies (Johnson & Johnson Services Inc.), and Smith & Nephew. The three players account for the largest market shares due to their strong brand presence and robust product portfolios.

The key players operating the market emphasize extensive R&D activities to develop innovative and effective orthopedic implants. They focus on devising ingenious growth strategies, including new product launches, technological developments, partnerships, collaborations, acquisitions, mergers, and others. For instance, IMPLANET announced its plans to acquire a spine implant manufacturer called Orthopedic & Spine Development (OSD) in March 2021.


Get your Customized Research Report:

https://www.fortunebusinessinsights.com/enquiry/customization/orthopedic-implants-market-101659


Key Players in the Global Market are:

  • Zimmer Biomet (Indiana, U.S.)
  • Medtronic
  • DePuy Synthes Companies (Johnson & Jonson Service Inc.) (Raynham, U.S.)
  • Smith & Nephew (London, U.K.)
  • Stryker (Michigan, U.S.)
  • ArthoCare Corporation (Texas, U.S.)
  • BioTek Instruments Inc. (Vermont, U.S.)
  • CONMED Corporation (New York, U.S.)
  • Integra LifeSciences Corporation (Massachusetts, U.S.)


About Us:

Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.


Contact Us:

US :+1 424 253 0390

UK : +44 2071 939123

APAC : +91 744 740 1245

Email:sales@fortunebusinessinsights.com

LinkedIn | Twitter | Blogs

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.